Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026)

Beyond Air (XAIR) reported Liabilities and Shareholders Equity of $35.4 million for Q1 2026, up 17.71% on a YoY basis from $30.1 million in Q1 2025, and down 3.78% sequentially from $36.8 million in Q4 2025.

Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

Beyond Air (XAIR) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $35.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 17.71% year-over-year to $35.4 million; the trailing twelve-month figure through Mar 2026 stood at $131.2 million (down 19.84% YoY), and the FY2026 full-year result was $35.4 million, up 17.71% from the prior year.
  • Liabilities and Shareholders Equity retreated to $35.4 million in Q1 2026, from $36.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $99.2 million in Q1 2022 to a low of $28.1 million in Q2 2025.
  • A 5-year average of $55.9 million and a median of $53.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 144.78% in 2022 and tumbled 47.22% in 2025, its largest moves.
  • Tracing XAIR's Liabilities and Shareholders Equity over 5 years: stood at $74.0 million in 2022, then declined by 29.81% to $51.9 million in 2023, then sank by 34.23% to $34.1 million in 2024, then rose by 7.7% to $36.8 million in 2025, then declined by 3.78% to $35.4 million in 2026.
  • Business Quant data shows XAIR's Liabilities and Shareholders Equity at $35.4 million in Q1 2026, $36.8 million in Q4 2025, and $31.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Beyond Air 2.25 Mn -10.02 Mn 94,000.00 35.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.39 Mn
Dec 31, 2025 36.77 Mn
Sep 30, 2025 30.97 Mn
Jun 30, 2025 28.11 Mn
Mar 31, 2025 30.06 Mn
Dec 31, 2024 34.14 Mn
Sep 30, 2024 53.01 Mn
Jun 30, 2024 46.50 Mn
Mar 31, 2024 56.96 Mn
Dec 31, 2023 51.91 Mn
Sep 30, 2023 58.01 Mn
Jun 30, 2023 73.04 Mn
Mar 31, 2023 68.75 Mn
Dec 31, 2022 73.96 Mn
Sep 30, 2022 82.04 Mn
Jun 30, 2022 91.90 Mn
Mar 31, 2022 99.20 Mn
Dec 31, 2021 99.31 Mn
Sep 30, 2021 54.06 Mn
Jun 30, 2021 44.17 Mn